Medeva shares dive on obesity drug fears
Thursday 17 July 1997
Dr Bill Bogie, chief executive, said sales of Ionamin had collapsed to pounds 7m in the first six months of this year from pounds 21m in the second half of 1996, and would be unlikely to recover in the short term after a warning from the US drug regulator last week linking anti-obesity pills with heart failure.
Analysts were surprised by the news on Ionamin and cut full-year forecasts for group profits from pounds 120m-pounds 132m to pounds 110m-pounds 115m.
First-half sales of Ionamin, which was bought from Rhone Poulenc last year and has been sold in the US since 1959, were affected by destocking and competition.
James Culverwell, an analyst at Merrill Lynch, said: "Medeva had always said that Ionamin would be a wild card, but no one thought it would be this bad." Analysts were also concerned about Ionamin's prospects, given that Roche's Xenical anti-fat pill, a safer breed of drug, could be launched shortly.
However, Dr Bogie said he still expected growth from Ionamin. "It's not like we've bought a dead duck. The obesity market is growing."
He warned that second half profits also depended on emerging competition for Methylphenidate, the group's leading drug for hyperactivity, which grew sales by 6 per cent to pounds 54m in the half year
Medeva has more than 70 per cent of the US market for this quota-controlled and licensed drug. However, three other generic companies, Johnson Matthey, Mallinckrodt and Ganes, have obtained licences. The first new generic drug is expected to enter the market by Christmas. Dr Bogie said although sales were likely to slip by around 15 per cent next year, the quota system would prevent a rush of lower-priced generics into the market.
Dr Bogie was upbeat over other products. "People should see that we are following our strategy. I am not worried about our share price. Glaxo made a remarkable turnaround after fears over Zantac."
However analysts were sceptical. Kevin Scotcher at NatWest said: "The great hope of replacing Methylphenidate with Ionamin has gone. And whether Medeva had good follow-up drugs is unclear."
Investment column, page 24
Children's bookseller wins The Independent's new author search
Board creates magnetic field to achieve lift
- 1 Jack the Ripper: Scientist who claims to have identified notorious killer has 'made serious DNA error'
- 2 Banksy arrest hoax: Internet duped by fake online report claiming artist's identity has been revealed
- 3 Former East 17 frontman Brian Harvey turns up at Downing Street and 'demands to speak to Prime Minister'
- 4 Kentucky gang rape: 15-year-old boy left in critical condition after sexual attack by group at party
- 5 Paralysed man Darek Fidyka walks again after treatment by British doctors on brink of 'cure'
Jack the Ripper: Scientist who claims to have identified notorious killer has 'made serious DNA error'
Oscar de la Renta dead: Legendary US fashion designer dies after long cancer battle aged 82
Oscar Pistorius: The brutal prison life that awaits disgraced athlete
Banksy arrest hoax: Internet duped by fake online report claiming artist's identity has been revealed
Super-sized ships arrive in Britain: How big can they get?
Cameron is warned 'no possibility' of UK reducing immigration and that bid to bring in quota on migrant workers would be illegal
Residents should throw a street party and mix with immigrant neighbours, councils told
Russell Brand threatened with arrest after filming outside Fox News headquarters
London bus driver 'kicks gay couple off for kissing'
Lord Freud: Tory welfare minister apologises after saying disabled people are 'not worth’ the minimum wage
Lord Freud hangs on as MPs of all parties 'call for his head' over disability comments
iJobs Money & Business
£23000 per annum + pension and 22 days holiday: Ashdown Group: An established ...
£27000 per annum + pension, 22 days holiday: Ashdown Group: An established ind...
£23000 - £26000 Per Annum: Clearwater People Solutions Ltd: Our client is curr...
£25 - 30k: Guru Careers: A Corporate Actions Administrator / Operations Admini...